Alimera Sciences Inc (ALIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 10,855 | 12,890 | 15,115 | 11,137 | 10,717 |
| Cost of Goods | 1,174 | 1,600 | 1,326 | 965 | 913 |
| Gross Profit | 9,681 | 11,290 | 13,789 | 10,172 | 9,804 |
| Operating Expenses | 13,445 | 13,285 | 14,043 | 13,332 | 13,495 |
| Operating Income | -3,590 | -1,395 | 72 | -2,195 | -2,778 |
| Interest Expense | 1,236 | 1,228 | 1,235 | 1,211 | 1,178 |
| Other Income | 49 | -69 | -83 | -16 | 32 |
| Pre-tax Income | -4,777 | -2,692 | -1,246 | -3,422 | -3,924 |
| Income Tax | 261 | 71 | 2 | 28 | 76 |
| Net Income Continuous | -5,038 | -2,763 | -1,248 | -3,450 | -4,000 |
| Net Income | $-5,038 | $-2,763 | $-1,248 | $-3,450 | $-4,000 |
| EPS Basic Total Ops | -1.06 | -0.59 | 0.29 | 6.00 | -0.90 |
| EPS Basic Continuous Ops | -1.06 | -0.59 | 0.45 | -0.74 | -0.86 |
| EPS Diluted Total Ops | -1.06 | -0.59 | 0.41 | 5.85 | -0.90 |
| EPS Diluted Continuous Ops | -1.06 | -0.59 | 0.47 | -0.73 | -0.86 |
| EBITDA(a) | $-2,727 | $-537 | $987 | $-1,343 | $-1,921 |